HUM vs VIR
Humana Inc (HUM) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. VIR currently screens at market cap $1.45B.
Not investment advice. Open the HUM and VIR stock pages for the full models.
Not investment advice.